Haemonetics Corporation (HAE)
Company Info
US4050241003
405024100
May 9, 1991
Highlights
$3.22B
$2.54
25.23
1.04
$1.37B
$719.40M
$263.04M
$58.80 - $97.97
$96.80
16.50%
7.94
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Haemonetics Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Haemonetics Corporation had a return of -17.92% year-to-date (YTD) and -11.43% in the last 12 months. Over the past 10 years, Haemonetics Corporation had an annualized return of 3.93%, while the S&P 500 had an annualized return of 11.29%, indicating that Haemonetics Corporation did not perform as well as the benchmark.
HAE
-17.92%
-12.79%
-13.47%
-11.43%
-11.75%
3.93%
^GSPC (Benchmark)
4.22%
2.22%
9.51%
22.46%
12.74%
11.29%
Monthly Returns
The table below presents the monthly returns of HAE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -11.57% | -17.92% | |||||||||||
| 2024 | -10.58% | -4.55% | 16.95% | 7.73% | -8.56% | -1.61% | 8.85% | -16.07% | 6.35% | -11.47% | 22.92% | -10.74% | -8.69% |
| 2023 | 7.57% | -8.07% | 6.40% | 1.16% | 1.06% | 0.64% | 8.34% | -2.72% | -0.17% | -4.86% | -5.12% | 5.74% | 8.72% |
| 2022 | -8.84% | 19.36% | 9.55% | -19.85% | 24.85% | 3.04% | 6.61% | 7.97% | -1.33% | 14.75% | 0.42% | -7.81% | 48.28% |
| 2021 | -3.76% | 10.68% | -12.25% | -39.41% | -16.06% | 18.03% | -8.78% | 3.22% | 12.49% | -2.66% | -25.41% | 3.49% | -55.33% |
| 2020 | -6.54% | 0.88% | -8.00% | 14.17% | -3.60% | -18.34% | -2.12% | 2.28% | -2.69% | 15.86% | 11.63% | 5.23% | 3.35% |
| 2019 | -1.14% | -12.17% | 0.70% | -0.23% | 11.13% | 24.07% | 1.45% | 9.38% | -5.53% | -4.29% | -0.11% | -4.73% | 14.84% |
| 2018 | 11.31% | 9.67% | 3.19% | 6.67% | 15.77% | -0.74% | 8.88% | 14.34% | 2.63% | -8.82% | 2.69% | -6.74% | 72.26% |
| 2017 | -0.85% | -6.35% | 8.68% | 3.23% | -2.63% | -3.16% | 4.15% | 4.60% | 4.30% | 6.00% | 21.53% | 0.48% | 44.48% |
| 2016 | -1.86% | 1.39% | 9.04% | -7.29% | -13.66% | 3.54% | 4.59% | 22.56% | -2.56% | -7.73% | 18.62% | 1.44% | 24.69% |
| 2015 | 5.83% | 12.27% | 1.03% | -9.77% | 1.95% | 0.10% | -3.26% | -9.75% | -10.50% | 4.52% | -4.56% | -0.00% | -13.84% |
| 2014 | -10.06% | -3.72% | -10.66% | -6.84% | 12.19% | 3.58% | 0.82% | 0.34% | -2.16% | 8.02% | -2.09% | 1.33% | -11.18% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HAE is 30, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Haemonetics Corporation (HAE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Haemonetics Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Haemonetics Corporation was 68.62%, occurring on Jan 27, 2022. The portfolio has not yet recovered.
The current Haemonetics Corporation drawdown is 54.05%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.62% | Feb 9, 2021 | 245 | Jan 27, 2022 | — | — | — |
| -60.48% | Nov 26, 2001 | 405 | Jul 7, 2003 | 419 | Mar 4, 2005 | 824 |
| -53.54% | Dec 31, 1993 | 326 | Apr 17, 1995 | 1201 | Jan 18, 2000 | 1527 |
| -46.33% | Aug 19, 2019 | 147 | Mar 18, 2020 | 224 | Feb 5, 2021 | 371 |
| -42.96% | Jul 26, 2013 | 706 | May 13, 2016 | 349 | Oct 2, 2017 | 1055 |
Volatility
Volatility Chart
The current Haemonetics Corporation volatility is 17.09%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Haemonetics Corporation compared to its peers in the Medical Instruments & Supplies industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for HAE in comparison to other companies of the Medical Instruments & Supplies industry. Currently, HAE has a PE value of 25.2. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for HAE in comparison to other companies of the Medical Instruments & Supplies industry. Currently, HAE has a PEG value of 1.0. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Haemonetics Corporation.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |